Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Samsung
Samsung
Activities:
Manufacturing
Hi Tech Manufacturing
Drug Delivery
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Immersive training programme implemented at Samsung Bioepis
Virtual-reality simulation education platform for the pharmaceutical and biotech industries has expanded its reach into Asia, most recently in South Korea
Manufacturing
Samsung Biologics first annual Sustainability Report
In the report, the company states its plans to build an eco-friendly business environment, supported by recently awarded ISO Certifications
Research & Development
DeepMatter collaborates with universities on manufacturing
The company will provide its DigitalGlassware software, a cloud-based platform that allows chemists to share data in real-time and digitally enable scale-up of advanced nanoparticle products
Regulatory
Samsung Biologics holds virtual ceremony for 10th anniversary
The company has also introduced an updated mission statement: "Driven. For Life."
Manufacturing
Samsung Bioepis opens Korea HQ for biologics
The building was completed in December 2020
Digital
Samsung Biologics launches Plant 4 virtual showroom
The company has recently launched digital initiatives including EQUIS, an electronic document and quality management system that gives clients real-time information about their products
Media
Biogen and Samsung Bioepis launch Imraldi in Europe
The product is the third anti-TNF biosimilar developed by Samsung Bioepis to be commercialised by Biogen across Europe
Subscribe now